Cargando…

Mushroom-Derived Compounds as Metabolic Modulators in Cancer

Cancer is responsible for lifelong disability and decreased quality of life. Cancer-associated changes in metabolism, in particular carbohydrate, lipid, and protein, offer a new paradigm of metabolic hits. Hence, targeting the latter, as well as related cross-linked signalling pathways, can reverse...

Descripción completa

Detalles Bibliográficos
Autores principales: Dowaraka-Persad, Bhoomika, Neergheen, Vidushi Shradha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9920867/
https://www.ncbi.nlm.nih.gov/pubmed/36771106
http://dx.doi.org/10.3390/molecules28031441
_version_ 1784887175382302720
author Dowaraka-Persad, Bhoomika
Neergheen, Vidushi Shradha
author_facet Dowaraka-Persad, Bhoomika
Neergheen, Vidushi Shradha
author_sort Dowaraka-Persad, Bhoomika
collection PubMed
description Cancer is responsible for lifelong disability and decreased quality of life. Cancer-associated changes in metabolism, in particular carbohydrate, lipid, and protein, offer a new paradigm of metabolic hits. Hence, targeting the latter, as well as related cross-linked signalling pathways, can reverse the malignant phenotype of transformed cells. The systemic toxicity and pharmacokinetic limitations of existing drugs prompt the discovery of multi-targeted and safe compounds from natural products. Mushrooms possess biological activities relevant to disease-fighting and to the prevention of cancer. They have a long-standing tradition of use in ethnomedicine and have been included as an adjunct therapy during and after oncological care. Mushroom-derived compounds have also been reported to target the key signature of cancer cells in in vitro and in vivo studies. The identification of metabolic pathways whose inhibition selectively affects cancer cells appears as an interesting approach to halting cell proliferation. For instance, panepoxydone exerted protective mechanisms against breast cancer initiation and progression by suppressing lactate dehydrogenase A expression levels and reinducing lactate dehydrogenase B expression levels. This further led to the accumulation of pyruvate, the activation of the electron transport chain, and increased levels of reactive oxygen species, which eventually triggered mitochondrial apoptosis in the breast cancer cells. Furthermore, the inhibition of hexokinase 2 by neoalbaconol induced selective cytotoxicity against nasopharyngeal carcinoma cell lines, and these effects were also observed in mouse models. Finally, GL22 inhibited hepatic tumour growth by downregulating the mRNA levels of fatty acid-binding proteins and blocking fatty acid transport and impairing cardiolipin biosynthesis. The present review, therefore, will highlight how the metabolites isolated from mushrooms can target potential biomarkers in metabolic reprogramming.
format Online
Article
Text
id pubmed-9920867
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99208672023-02-12 Mushroom-Derived Compounds as Metabolic Modulators in Cancer Dowaraka-Persad, Bhoomika Neergheen, Vidushi Shradha Molecules Review Cancer is responsible for lifelong disability and decreased quality of life. Cancer-associated changes in metabolism, in particular carbohydrate, lipid, and protein, offer a new paradigm of metabolic hits. Hence, targeting the latter, as well as related cross-linked signalling pathways, can reverse the malignant phenotype of transformed cells. The systemic toxicity and pharmacokinetic limitations of existing drugs prompt the discovery of multi-targeted and safe compounds from natural products. Mushrooms possess biological activities relevant to disease-fighting and to the prevention of cancer. They have a long-standing tradition of use in ethnomedicine and have been included as an adjunct therapy during and after oncological care. Mushroom-derived compounds have also been reported to target the key signature of cancer cells in in vitro and in vivo studies. The identification of metabolic pathways whose inhibition selectively affects cancer cells appears as an interesting approach to halting cell proliferation. For instance, panepoxydone exerted protective mechanisms against breast cancer initiation and progression by suppressing lactate dehydrogenase A expression levels and reinducing lactate dehydrogenase B expression levels. This further led to the accumulation of pyruvate, the activation of the electron transport chain, and increased levels of reactive oxygen species, which eventually triggered mitochondrial apoptosis in the breast cancer cells. Furthermore, the inhibition of hexokinase 2 by neoalbaconol induced selective cytotoxicity against nasopharyngeal carcinoma cell lines, and these effects were also observed in mouse models. Finally, GL22 inhibited hepatic tumour growth by downregulating the mRNA levels of fatty acid-binding proteins and blocking fatty acid transport and impairing cardiolipin biosynthesis. The present review, therefore, will highlight how the metabolites isolated from mushrooms can target potential biomarkers in metabolic reprogramming. MDPI 2023-02-02 /pmc/articles/PMC9920867/ /pubmed/36771106 http://dx.doi.org/10.3390/molecules28031441 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Dowaraka-Persad, Bhoomika
Neergheen, Vidushi Shradha
Mushroom-Derived Compounds as Metabolic Modulators in Cancer
title Mushroom-Derived Compounds as Metabolic Modulators in Cancer
title_full Mushroom-Derived Compounds as Metabolic Modulators in Cancer
title_fullStr Mushroom-Derived Compounds as Metabolic Modulators in Cancer
title_full_unstemmed Mushroom-Derived Compounds as Metabolic Modulators in Cancer
title_short Mushroom-Derived Compounds as Metabolic Modulators in Cancer
title_sort mushroom-derived compounds as metabolic modulators in cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9920867/
https://www.ncbi.nlm.nih.gov/pubmed/36771106
http://dx.doi.org/10.3390/molecules28031441
work_keys_str_mv AT dowarakapersadbhoomika mushroomderivedcompoundsasmetabolicmodulatorsincancer
AT neergheenvidushishradha mushroomderivedcompoundsasmetabolicmodulatorsincancer